Fischer Medical Ventures zooms on partnering with City of Jember, Indonesia
Fischer Medical Ventures is currently trading at Rs. 851.20, up by 74.25 points or 9.56% from its previous closing of Rs. 776.95 on the BSE.
The scrip opened at Rs. 796.40 and has touched a high and low of Rs. 860.00 and Rs. 783.00 respectively. So far 12815 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 919.00 on 28-Mar-2025 and a 52 week low of Rs. 573.60 on 21-Aug-2024.
Last one week high and low of the scrip stood at Rs. 860.00 and Rs. 771.75 respectively. The current market cap of the company is Rs. 5341.82 crore.
The promoters holding in the company stood at 61.80%, while Institutions and Non-Institutions held 6.97% and 31.23% respectively.
Fischer Medical Ventures has partnered with the City of Jember, Indonesia, to deploy portable, AI-powered X-ray systems aimed at eradicating tuberculosis by 2026. This initiative marks the company’s strategic healthcare entry into Indonesia, combining innovation, access, and impact to transform public health outcomes. The company is estimating the program value to be over $10 million with an implementation plan over 2 years in multiple phases.
For the Company, this initiative is not just exercising its corporate social responsibility, it is a strategic move into a 280 million population country with huge opportunities from its public health plans, especially to fight TB, an infectious disease that can lead to death if not treated promptly. Indonesia continues to battle one of the highest burdens of TB in the world, alongside India and China. A key challenge remains: limited access to early detection and treatment
Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.
.jpg)
